Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03980041 |
Title | Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275) |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Infinity Pharmaceuticals, Inc. |
Indications |
urethra transitional cell carcinoma |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | ITA | FRA | ESP |